Demerol — Class III drug recall D-1226-2014
Terminated recall by Hospira Inc., reported 2014-04-16, distributed nationwide. Labeling; Missing label; ampoules are missing the immediate container label
| Recall number | D-1226-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2014-03-25 |
| Classified | 2014-04-08 |
| Reported by FDA | 2014-04-16 |
| Terminated | 2015-12-18 |
| Distributed | Nationwide (US) |
| Quantity | 237,850 ampules |
| Reason classes | labeling |
| NDC | 00409-1203-01 |
| Lot numbers | 1OCT2014, 221303A |
Product
Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.
Reason for recall
Labeling; Missing label; ampoules are missing the immediate container label
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1226-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.